Molecular Involvement and Prognostic Importance of Fms-like Tyrosine Kinase 3 in Acute Myeloid Leukemia

被引：3

作者：

Shahab, Sadaf ^{[1
]}

Shamsi, Tahir S. ^{[1
]}

Ahmed, Nuzhat ^{[1
]}

机构：

[1] Natl Inst Blood Dis & Bone Marrow Transplantat, Karachi, Pakistan

来源：

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2012年 / 13卷 / 09期

关键词：

AML; FLT3; ITDs; (TKD); leukemia-specific recognition markers; prognostic marker; INTERNAL TANDEM DUPLICATION; FLT3; GENE; MYELODYSPLASTIC SYNDROME; MYELOGENOUS LEUKEMIA; NORMAL CYTOGENETICS; MUTATIONS; ASSOCIATION; IDENTIFICATION; ACTIVATION; EXPRESSION;

D O I：

10.7314/APJCP.2012.13.8.4215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML (Acute myeloid leukemia) is a form of blood cancer where growth of myeloid cells occurs in the bone marrow. The prognosis is poor in general for many reasons. One is the presence of leukaemia-specific recognition markers such as FLT3 (fms-like tyrosine kinase 3). Another name of FLT3 is stem cell tyrosine kinase-1 (STK1), which is known to take part in proliferation, differentiation and apoptosis of hematopoietic cells, usually being present on haemopoietic progenitor cells in the bone marrow. FLT3 act as an independent prognostic factor for AML. Although a vast literature is available about the association of FLT3 with AML there still is a need of a brief up to date overview which draw a clear picture about this association and their effect on overall survival.

引用

页码：4215 / 4220

页数：6

共 63 条

[1] Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia [J].

Abu-Duhier, FM ;

Goodeve, AC ;

Wilson, GA ;

Care, RS ;

Peake, IR ;

Reilly, JT .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :983-988

[2] Genomic structure of human FLT3:: Implications for mutational analysis [J].

Abu-Duhier, FM ;

Goodeve, AC ;

Wilson, GA ;

Care, RS ;

Peake, IR ;

Reilly, JT .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :1076-1077

[3] FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia [J].

Arrigoni, P ;

Beretta, C ;

Silvestri, D ;

Rossi, V ;

Rizzari, C ;

Valsecchi, MG ;

Cazzaniga, G ;

Biondi, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :89-92

[4] THE EXPRESSION OF FMS, KIT AND FLT3 IN HEMATOPOIETIC MALIGNANCIES [J].

BIRG, F ;

ROSNET, O ;

CARBUCCIA, N ;

BIRNBAUM, D .

LEUKEMIA & LYMPHOMA, 1994, 13 (3-4) :223-227

[5]

BLOOMFIELD C D, 1984, Cancer Genetics and Cytogenetics, V11, P332

[6] Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype [J].

Boissel, N ;

Renneville, A ;

Biggio, V ;

Philippe, N ;

Thomas, X ;

Cayuela, JM ;

Terre, C ;

Tigaud, I ;

Castaigne, S ;

Raffoux, E ;

De Botton, S ;

Fenaux, P ;

Dombret, H ;

Preudhomme, C .

BLOOD, 2005, 106 (10) :3618-3620

[7] Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia [J].

Colovic, Natasa ;

Tosic, Natasa ;

Aveic, Sanja ;

Djuric, Marija ;

Milic, Natasa ;

Bumbasirevic, Vladimir ;

Colovic, Milica ;

Pavlovic, Sonja .

ANNALS OF HEMATOLOGY, 2007, 86 (10) :741-747

[8] Molecular characterization of acute myeloid leukemia [J].

Doehner, Konstanze ;

Doehner, Hartmut .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (07) :976-982

[9]

Elisa C, 2011, BLOOD, P1

[10]

Farhad Z, 2010, ARCH IRAN MED, V13, P21

← 1 2 3 4 5 6 7 →